MAM
Swiggy Instamart joins Mumbai’s world cup victory parade
Mumbai: Amidst the celebration of winning the T20 World Cup 2024, Swiggy Instamart, joined the celebration at the world cup victory parade for the Indian cricket team at Marine Drive in Mumbai yesterday.
The vibrant streets of Mumbai’s Marine Drive were painted in hues of orange as Swiggy Instamart’s delivery executives attended the event wearing its signature orange t-shirts to greet the Indian cricket team. Emblazoned with “Greatness, delivered” on their jerseys, Swiggy Instamart celebrated the joy of bringing the world cup back home for the first time since 2011 with millions of cricket fans at the parade. Additionally, 30 satin orange-themed banners proudly proclaimed, “Best delivery ever!” for the Indian cricket team, adding a striking visual element to the sea of blue.
Swiggy Instamart’s presence at the parade echoes its commitment to delivering both convenience and celebration to customers nationwide.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
